Welcome to CPAP-Europe

Obstructive Sleep Apnoea (OSA) is a chronic, progressive syndrome that affects an estimated 4% of Adult men and 2% of all Adult women. Sleeping problems and sleep disorders are amongst the most common problems we suffer from.

Published figures concerning the condition state the following facts: 15 Million people snoring in the UK, 10.5m are men and 4.5m are women. 30 million people are affected by snoring. 58% of people who snore are aged 50-59 years. Everyone knows someone who snores! No wonder people are looking for a treatment or solution to give them a better nights sleep.

Obstructive Sleep Apnoea

Obstructive Sleep Apnoea occurs due to an obstruction or anatomical narrowing of the upper airway in the pharynx that impedes, or reduces, inspiratory airflow (inhaling). Conventional therapy is the use of a device that provides Continuous Positive Airway Pressure (CPAP), supplied through a mask. This use of continuous pressure, when titrated properly, eliminates obstructive breathing events, including snoring. This makes these CPAP units not only highly effective in treating sleep apnoea but also very effective as an anti-snoring device.